Myrexis, Inc. (formerly Myriad Pharmaceuticals, Inc.) is a biotechnology company focused on discovering, developing, and commercializing novel therapies for the treatment of cancer. Our pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemical structures that have the potential to be first-in-class and/or best-in-class therapeutics.